Letter of Acceptance for EP. Pat. No. 3507002
MADISON, WI, January 11, 2022 /24-7PressRelease/ — Bioionix, Inc, (www.bioionix.com) a technology platform company that develops, manufactures and distributes proprietary electrolytic systems to eliminate biological and chemical contaminants from water, announced today that the European. Patent Office issued the Letter of Acceptance for EP. Pat. No. 3507002 covering the configuration for electrochemical water treatment.
Bioionix, Inc. is a pioneer in the innovation of electrochemical water disinfection. The process works without the addition of chemical compounds to the water and promotes high fluid velocity to promote recycling of liquids and therefore a sustainable solution. The Bioionix HDI innovative electrolytic disinfection process is utilized on seawater for elimination of the harmful microalgae Alexandrum cantenella, better known as “Red Tide.” The system can treat enormous liquid flow rates removing contaminants that damage the environment and sea life.
The Bioionix process creates oxidizing disinfectants from the water itself, using a low voltage electrical field and high-performance catalytic plates to completely penetrate liquid streams, even at high turbidity or organic load. The SuperOxidants™ produced provide immediate and lasting decontamination, eliminating suspended pathogens and biofilms in seconds. The Bioionix CXS™ systems are also used in food manufacturing to destroy foodborne pathogens such as listeria, salmonella, E.coli in brine and spray interventions.
Ryan Karns, Bioionix Sales Manager states, “Bioionix is currently exploring opportunities to market this technology into multiple industries with brine or seawater impacted by biological contamination, such as desalinization plants and ship ballast water.” Interest in this innovative and sustainable solution has gained worldwide attention since 2018 when the technology was approved for Red Tide destruction by the Chilean government to support its salmon fishing industry. Pete Marsnik, Bioionix CEO goes on to state, “This asset further strengthens the Bioionix disinfection technology platform and our intellectual portfolio. We are very pleased with this news, congratulations to the entire Bioionix team.”
About Bioionix, Inc. –
www.bioionix.com Bioionix, Inc., headquartered in McFarland, WI, USA, is a technology platform company that develops, manufactures and distributes proprietary electrolytic systems to eliminate pathogens and other microbials from water. In the area of seawater treatment, the company has developed a breakthrough for water microbial safety and reuse without chemicals which can affect taste, safety and quality. The Bioionix system uses specialized catalysts to directly disinfect water, brine and turbid processing liquids by generating a powerful combination of reactive oxygen and activated chlorine species directly from the liquid itself. These Bioionix SuperOxidants™ attack microbials by complementary methods of action, including direct DNA destruction, cytoplasm impairment, and cell wall disruption. Other SuperOxidants™ provide powerful residual disinfection throughout the processing systems.
For the original version of this press release, please visit 24-7PressRelease.com here